首页 > 

slot super ace jili games gameplay

2025-01-14
CARLSBAD, Calif.--(BUSINESS WIRE)--Nov 21, 2024-- Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the first closing of its previously announced registered direct offering for the purchase and sale of up to an aggregate of 39,473,688 of Lineage’s common shares and accompanying warrants (the “common warrants”) to purchase an aggregate of up to 39,473,688 of Lineage’s common shares at a combined purchase price of $0.76 per common share and accompanying common warrant. Lineage issued an aggregate of 31,578,951 common shares and common warrants to purchase up to 31,578,951 common shares to certain healthcare focused institutional investors in the first closing. Each common warrant will be exercisable for one common share at an exercise price of $0.91 per common share and will be exercisable commencing six months following their date of issuance and will expire on the earlier of (a) the three-year anniversary of the initial exercise date, and (b) the 90th day following the date of the public disclosure of the intent to advance OpRegen ® (also known as RG6501) into a multi-center phase 2 or 3 clinical trial which includes a control or comparator arm, or if the date of such public disclosure occurs prior to the initial exercise date of the common warrants, the 90th day following the initial exercise date. H.C. Wainwright & Co. served as the exclusive placement agent for the offering. The offering of the securities to Broadwood Partners, L.P. (“Broadwood”), an affiliate of Neal Bradsher, a member of Lineage’s board of directors, is expected to close upon obtaining shareholder approval to satisfy applicable NYSE American rules and to the satisfaction of customary closing conditions. The common warrants that may be issued to Broadwood pursuant to the definitive purchase agreement entered into between Lineage and Broadwood will not be exercisable until the later of (i) their date of issuance, which will be the date shareholder approval is obtained, and (ii) the six-month anniversary of the date of issuance of the common warrants to the unaffiliated institutional investors in the offering. Lineage received $24 million in aggregate gross proceeds in the first closing of the offering, which was with respect to the investments by the unaffiliated institutional investors, and expects to receive approximately $6 million in additional gross proceeds from the offering with respect to the investment by Broadwood, in each case, before deducting the placement agent’s fees and other offering expenses payable by Lineage. The potential additional gross proceeds to Lineage from the common warrants, if fully exercised on a cash basis, will be approximately $36 million. No assurance can be given that Lineage will obtain the shareholder approval required to satisfy applicable NYSE American rules in order to sell the securities in the offering to Broadwood or that any of the common warrants will be exercised. Lineage currently plans to use the net proceeds from the offering for working capital and general corporate purposes, including research and development expenses and capital expenditures. The securities described above were offered and sold by Lineage in a registered direct offering pursuant to a “shelf” registration statement on Form S-3 (File No. 333-277758) filed with the Securities and Exchange Commission (the “SEC”) on March 7, 2024, and which was declared effective by the SEC on May 14, 2024. The offering of the securities in the registered direct offering was made only by means of a base prospectus and a prospectus supplement that forms a part of the effective registration statement. A final prospectus supplement and the accompanying base prospectus relating to the offering were filed with the SEC and are available on the SEC’s website at www.sec.gov . Electronic copies of the final prospectus supplement and the accompanying base prospectus may also be obtained from H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 856-5711 or e-mail at placements@hcwco.com . This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Lineage Cell Therapeutics, Inc. Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel, “off-the-shelf,” cell therapies to address unmet medical needs. Lineage’s programs are based on its proprietary cell-based technology platform and associated development and manufacturing capabilities. From this platform, Lineage designs, develops, manufactures, and tests specialized human cells with anatomical and physiological functions similar or identical to cells found naturally in the human body. These cells are created by applying directed differentiation protocols to established, well-characterized, and self-renewing pluripotent cell lines. These protocols generate cells with characteristics associated with specific and desired developmental lineages. Cells derived from such lineages are transplanted into patients in an effort to replace or support cells that are absent or dysfunctional due to degenerative disease, aging, or traumatic injury, and to restore or augment the patient’s functional activity. Lineage’s neuroscience focused pipeline currently includes: (i) OpRegen, a retinal pigment epithelial cell therapy in Phase 2a development under a worldwide collaboration with Roche and Genentech, a member of the Roche Group, for the treatment of geographic atrophy secondary to age-related macular degeneration; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of spinal cord injuries; (iii) ReSonanceTM (ANP1), an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy; (iv) PNC1, a photoreceptor neural cell therapy for the potential treatment of vision loss due to photoreceptor dysfunction or damage; and (v) RND1, a novel hypoimmune induced pluripotent stem cell line being developed in collaboration with Factor Bioscience Limited. For more information, please visit www.lineagecell.com or follow the company on X/Twitter @LineageCell . Forward-Looking Statements Lineage cautions you that all statements, other than statements of historical fact, in this press release, are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as “believe,” “aim,” “may,” “will,” “estimate,” “continue,” “anticipate,” “design,” “intend,” “expect,” “could,” “can,” “plan,” “potential,” “predict,” “seek,” “should,” “would,” “contemplate,” “project,” “target,” “tend to,” or the negative version of these words and similar expressions. Lineage’s forward-looking statements are based upon its current expectations and beliefs and involve assumptions that may never materialize or may prove to be incorrect. Such statements include, but are not limited to, statements relating to the closing of the offering of the securities to Broadwood, the total potential amount and use of proceeds from the offering, the exercise of the common warrants in cash prior to their expiration and the exercise of the common warrants upon the achievements of such milestone events or otherwise prior to their expiration. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the risks that the offering may not close due to the failure to satisfy the applicable closing conditions, including, with respect to the offering of securities to Broadwood, obtaining shareholder approval to satisfy applicable NYSE American rules, and that the common warrants may not be exercised or, if exercised, the exercise price may not be paid in cash, and those risks and uncertainties inherent in Lineage’s business and other risks discussed in Lineage’s filings with the SEC. Further information regarding these and other risks is included under the heading “Risk Factors” in Lineage’s periodic reports with the SEC, including Lineage’s most recent Annual Report on Form 10-K filed with the SEC and its other subsequent reports, which are available from the SEC’s website. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Lineage undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. View source version on businesswire.com : https://www.businesswire.com/news/home/20241121738269/en/ CONTACT: Lineage Cell Therapeutics, Inc. IR Ioana C. Hone (ir@lineagecell.com) (442) 287-8963Russo Partners – Media Relations Nic Johnson or David Schull (Nic.johnson@russopartnersllc.com) (David.schull@russopartnersllc.com) (212) 845-4242 KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: HEALTH NEUROLOGY GENETICS CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY SOURCE: Lineage Cell Therapeutics, Inc. Copyright Business Wire 2024. PUB: 11/21/2024 05:00 PM/DISC: 11/21/2024 05:02 PM http://www.businesswire.com/news/home/20241121738269/enslot super ace jili games gameplay

One of my fondest childhood memories was taking family roadtrips to cities. Where we lived in rural South Central Pennsylvania was simple and quiet, so getting up close to famous landmarks like Washington, D.C.’s Lincoln Memorial and seeing so much diversity and energy in one place was a welcome change of scenery. I still get a thrill out of visiting urban American destinations. In contrast to the jaunts of my youth, though, I prefer doing these trips solo now. While having a companion has its time and place—typically for longer overeas vacations that require more detailed planning—I love exploring American cities indendently at my own pace. And though choosing a solid hotel proved challenging in the past, this year I’ve become loyal to a brand that may surprise you: Canopy by Hilton . Unveiled in 2014, Canopy by Hilton is the global hospitality brand ’s first lifestyle brand combining the best qualities of boutique hotels (modern design, locally-curated food and drink) and dependable hotel chains (safety, amenities like gyms) with addresses in the world’s most desirable destinations. Hilton Honors members and jetsetters alike responded favorably to the launch; currently, there are are 45 Canopy locations worldwide, with 29 in the pipeline. And compared to other higher-end properties, Canopy’s nightly rates are very competitively priced under $300. To experience the brand’s ever-growing appeal—and learn why it’s such a smart choice for solo female travelers—I visited two Canopy properties on opposite sides of the country, Canopy by Hilton Portland Pearl District and Canopy by Hilton Portland Waterfront , a couple months ago. Here’s what you can enjoy across all Canopy by Hilton hotels: a warm staff that’s eager to help with no air of stuffiness. You’ll also be welcomed with a modern and residental-feeling design; common spaces are kitted out with ample seating and tables for working, socializing, and everything in between. The signature Just-Right accommodations are true to their name: entry-level rooms are space-saving yet savvy with their open configurations, oversized windows for maximum light, and low-slung Canopy Serta beds, while suites merge the comforts of home with the convenience of a full-service hotel. Other standard perks include water stations and glass bottles—sustainability is one of the Canopy’s key pillars—Nespresso machines in every room, and a fitness enter. What makes every Canopy by Hilton hotel special, however, is the locally-curated food and beverage. It would have been easy for the brand to roll out the same culinary offerings across its portfolio; instead, each property gets to showcase what makes their hometowns unique and different. At Vaux , Canopy by Hilton Portland Pearl District’s all-day restaurant and bar, the menu reflects Portland touches and global influences (think: warm pretzel with Tillamook beer cheese, sausage-topped Oregon corn polenta, pastrami sandwich with local pale ale-infused sauerkraut). The beverages, too, pay homage to the region with a strong showing from area breweries (Occidental Kolsch, Migration Straight Outta Portland) and wineries (A to Z, Lange). Meanwhile, Canopy by Hilton Portland Waterfront’s two dining concepts, Salt Yard and Luna Rooftop Bar , turn out the iconic foods Maine’s biggest city is famous for—and much more. An open, industrial-feeling space that transforms from daytime cafe to evening lounge, Salt Yard serves up a tender lobster roll brightened by citrus aioli alongside lesser-known Portland sips and bites like Rwanda Bean coffee and Orchard Ridge Farm bagels. But it’s tough to top the appeal of Luna Rooftop Bar, where you’ll see locals and hotel guests savoring icy local oysters and Maine crab bruschetta with the tranquil waterfront as the backdrop. It’s a lovely place to enjoy everything that makes Portland such a beloved destination.Robbie Avila scores 19 to lead Saint Louis over winless Chicago State 85-62CAPE CANAVERAL, Fla. (AP) — Known across the globe as the stuck astronauts, Butch Wilmore and Suni Williams hit the six-month mark in space Thursday with two more to go. The pair rocketed into orbit on June 5, the first to ride Boeing’s new Starliner crew capsule on what was supposed to be a weeklong test flight. They arrived at the International Space Station the next day, only after overcoming a cascade of thruster failures and helium leaks . NASA deemed the capsule too risky for a return flight, so it will be February before their long and trying mission comes to a close. While NASA managers bristle at calling them stuck or stranded, the two retired Navy captains shrug off the description of their plight. They insist they’re fine and accepting of their fate. Wilmore views it as a detour of sorts: “We’re just on a different path.” “I like everything about being up here,” Williams told students Wednesday from an elementary school named for her in Needham, Massachusetts, her hometown. "Just living in space is super fun.” Both astronauts have lived up there before so they quickly became full-fledged members of the crew, helping with science experiments and chores like fixing a broken toilet, vacuuming the air vents and watering the plants. Williams took over as station commander in September. “Mindset does go a long way,” Wilmore said in response to a question from Nashville first-graders in October. He’s from Mount Juliet, Tennessee. “I don’t look at these situations in life as being downers.” Boeing flew its Starliner capsule home empty in September, and NASA moved Wilmore and Williams to a SpaceX flight not due back until late February. Two other astronauts were bumped to make room and to keep to a six-month schedule for crew rotations. Like other station crews, Wilmore and Williams trained for spacewalks and any unexpected situations that might arise. “When the crews go up, they know they could be there for up to a year,” said NASA Associate Administrator Jim Free. NASA astronaut Frank Rubio found that out the hard way when the Russian Space Agency had to rush up a replacement capsule for him and two cosmonauts in 2023, pushing their six-month mission to just past a year. Boeing said this week that input from Wilmore and Williams has been “invaluable" in the ongoing inquiry of what went wrong. The company said in a statement that it is preparing for Starliner's next flight but declined comment on when it might launch again. NASA also has high praise for the pair. “Whether it was luck or whether it was selection, they were great folks to have for this mission,” NASA's chief health and medical officer, Dr. JD Polk, said during an interview with The Associated Press. On top of everything else, Williams, 59, has had to deal with “rumors,” as she calls them, of serious weight loss. She insists her weight is the same as it was on launch day, which Polk confirms. During Wednesday's student chat, Williams said she didn't have much of an appetite when she first arrived in space. But now she's “super hungry” and eating three meals a day plus snacks, while logging the required two hours of daily exercise. Williams, a distance runner, uses the space station treadmill to support races in her home state. She competed in Cape Cod’s 7-mile Falmouth Road Race in August. She ran the 2007 Boston Marathon up there as well. She has a New England Patriots shirt with her for game days, as well as a Red Sox spring training shirt. “Hopefully I’ll be home before that happens -- but you never know,” she said in November. Husband Michael Williams, a retired federal marshal and former Navy aviator, is caring for their dogs back home in Houston. As for Wilmore, 61, he's missing his younger daughter's senior year in high school and his older daughter's theater productions in college. “We can’t deny that being unexpectedly separated, especially during the holidays when the entire family gets together, brings increased yearnings to share the time and events together,” his wife, Deanna Wilmore, told the AP in a text this week. Her husband “has it worse than us” since he's confined to the space station and can only connect via video for short periods. “We are certainly looking forward to February!!” she wrote. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Docusign Announces Third Quarter Fiscal 2025 Financial ResultsBerkshire Hills Bancorp, Inc. ( NYSE:BHLB – Get Free Report ) has earned an average recommendation of “Moderate Buy” from the six ratings firms that are currently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $29.70. Several brokerages have commented on BHLB. Royal Bank of Canada lowered their price target on Berkshire Hills Bancorp from $32.00 to $31.00 and set a “sector perform” rating on the stock in a report on Tuesday, December 17th. Seaport Res Ptn upgraded shares of Berkshire Hills Bancorp from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 16th. Piper Sandler raised shares of Berkshire Hills Bancorp from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 16th. Finally, Keefe, Bruyette & Woods upped their price target on shares of Berkshire Hills Bancorp from $32.00 to $34.50 and gave the stock a “market perform” rating in a research note on Tuesday, December 24th. Get Our Latest Stock Report on BHLB Institutional Trading of Berkshire Hills Bancorp Berkshire Hills Bancorp Price Performance Shares of NYSE:BHLB opened at $28.30 on Friday. Berkshire Hills Bancorp has a 52 week low of $20.50 and a 52 week high of $32.36. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $1.22 billion, a P/E ratio of 29.79 and a beta of 0.88. The firm’s 50 day moving average is $29.45 and its two-hundred day moving average is $26.88. Berkshire Hills Bancorp ( NYSE:BHLB – Get Free Report ) last issued its quarterly earnings results on Thursday, October 24th. The savings and loans company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.55 by $0.03. Berkshire Hills Bancorp had a return on equity of 8.68% and a net margin of 5.86%. The firm had revenue of $125.70 million during the quarter, compared to analyst estimates of $119.61 million. During the same period last year, the company posted $0.50 EPS. The firm’s quarterly revenue was up 16.6% on a year-over-year basis. Analysts anticipate that Berkshire Hills Bancorp will post 2.16 earnings per share for the current year. Berkshire Hills Bancorp Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Wednesday, November 27th. Shareholders of record on Thursday, November 14th were issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 2.54%. The ex-dividend date of this dividend was Thursday, November 14th. Berkshire Hills Bancorp’s dividend payout ratio (DPR) is 75.79%. About Berkshire Hills Bancorp ( Get Free Report Berkshire Hills Bancorp, Inc operates as the bank holding company for Berkshire Bank that provides various banking products and services in the United States. The company provides various deposit accounts, including demand deposit, interest-bearing checking, regular savings, money market savings, time certificates of deposit, and retirement deposit accounts. Read More Receive News & Ratings for Berkshire Hills Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Berkshire Hills Bancorp and related companies with MarketBeat.com's FREE daily email newsletter .

Robbie Avila scores 19 to lead Saint Louis over winless Chicago State 85-62WEST FARGO — When Happy, a sweet but oblivious-to-danger 9-year-old mare scraped up her back leg once again, owner Alicia Severson was able to call on Casselton Veterinary Service to visit her Gandin, N.D., farm and patch up Happy. But when it comes to a recurring ligament injury Happy sustained while competing in a barrel competition, Severson and many other horse and farm animal owners are finding it more difficult every year to find big animal veterinarians, and especially ones that specialize in certain care. ADVERTISEMENT "There is absolutely a shortage," Severson said. For decades, ranchers have been sounding the alarm about a shortage of rural veterinarians and new big animal vets, and especially those who specialize in caring for horses, cows, pigs and sheep. The problem persists despite land grant universities such as North Dakota State University, who often send undergraduates interested in the profession to far-away schools for continuing education. According to the U.S. Department of Agriculture , 500 counties across 46 states reported critical shortages of big animal vets. And while large animal veterinarians have long been a challenge to find in rural areas, where they are most needed, veterinarians who specialize in horses are also waning. That's despite the increasing popularity and availability in North Dakota and Minnesota for younger generations to compete in equine activities. According to an online database, about 43,200 horses call North Dakota home, which is about one horse per 18 people in the state. Leon Glasser, president of the North Dakota Quarter Horse Racing Association, has been breeding, raising and racing horses for more than 40 years, working to improve the quality of racehorses born in North Dakota. Over the years, he's watched the number of veterinarians willing to work with horses dwindle quickly. "Are we short of equine vets in this area? Absolutely, we are," Glasser said. He said a veterinary clinic in New Salem, N.D., will now only provide simple paperwork needed for owners to transport horses across state lines for care and Missouri Valley Vet Clinic in Bismarck has also limited equine services in the same way. Most newer veterinarians prefer to work on dogs and cats exclusively, he said. ADVERTISEMENT Severson agreed, noting it is also difficult to find a veterinarian who has experience treating goats, as the Seversons have two goats at their farm along with the horses and a cat. For Happy's ligament issue, of which she's had recurring surgeries and needs sporadic treatment, Severson worked with an equine sports medicine specialist based in the Twin Cities but would travel into western Minnesota. However, that veterinarian recently retired, leaving Severson on the hunt to find another specialist within a few hundred miles of the Red River Valley. "Nothing takes the place of a seasoned veterinarian," Severson said. "Thankfully, Casselton [Veterinary Service] is fabulous when it comes to when my horse is injured. But when it comes to long-term stuff that she's dealing with, it's difficult." Dr. Alexa Weyer at Casselton Veterinary grew up in Snohomish, Wash., a farm town north of Seattle, and graduated with a bachelor's degree in biology from the University of North Dakota before finishing her doctorate in Veterinary Medicine at Auburn University in Alabama. Following graduation, she began working at Casselton Veterinary in early 2021. "There is definitely a shortage of people interested in large animal practice, and we would love to see more interest," Weyer said. To be a veterinarian requires a doctorate degree from a veterinary school or program accredited by the American Veterinary Medical Association and passing the North American Veterinary Licensing Exam, which is an extensive 360-question exam on all species (dogs, cats, horses, cows, goats, pigs, birds, reptiles, rabbits, fish and more) and all aspects of veterinary medicine. ADVERTISEMENT Veterinarians can choose to either go straight into general practice after graduation or they can seek further education to become a specialist. To be a veterinarian technician requires a two- or four-year veterinary technology degree, depending on the program. Derine Winning, a veterinarian at Valley Veterinary Hospital in Fargo and public policy adviser for the North Dakota Veterinary Medical Association, said the vast majority — about 70% — of new graduate veterinarians became companion animal practitioners in 2023. Almost 10% became mixed animal practitioners and only 6% became equine practitioners. The data comes from the American Veterinary Medical Association's 2024 Economic State of the Profession Report. "There are a lot of different areas in which veterinarians can become board certified through advanced education and training," Winning said. Animal specialists of any kind can be difficult to find locally, although Winning said the Red River Animal and Emergency Hospital and Referral Center in Fargo does have some specialists in oncology, surgery, internal medicine and emergency and critical care. Casselton Veterinary provides many large animal services from emergency on-call care to posting a doctor and technician for nights and weekends. In addition to their vets traveling to farms, the clinic has a large treatment area with two stocks and stalls for hospitalization and breeding care. The clinic also has several portable imaging tools. Weyer said the trend of vets moving away from rural areas can be seen in the growing need for referrals. "Unfortunately, most referral facilities across the country for large and small animals are in areas of high population density. For large animals, there are even fewer facilities and they tend to be at universities with veterinary schools or in areas of high equine concentration," she said. ADVERTISEMENT While the Casselton doctors work with a variety of places for specialty referrals, Sturgis Equine in western South Dakota and the University of Minnesota are probably most used by the clinic. Still, the closest drive is about four hours. Weyer said referrals are typically needed for colic surgery, arthroscopic surgery, advanced imaging or advanced hospitalizations. "In general practice like we are, there are always times to refer. For our clients, it would be nice to have a closer option, but a lot of areas in the country are even farther from referral than we are," Weyer said. Beth Carlson, deputy veterinarian with the North Dakota Department of Agriculture, said rural areas most in need of large animal veterinarians may not attract college graduates with those abilities. "The ratio of large animal veterinarians has shifted quite a bit," Carlson said. "Certainly there are areas of the state where it is difficult to hire veterinarians for a variety of reasons. In some cases it's challenging to hire veterinarians even in urban areas as well." One challenge is the cost of becoming a veterinarian. The USDA offers a program that provides up to $75,000 in veterinary school loan repayment to graduates who agree to work in underserved rural communities a minimum of three years. While some in Congress have recently proposed increasing that amount, it can still be daunting as new veterinarians, on average, face about $190,000 in school debt over the eight years needed to become a veterinarian. ADVERTISEMENT According to the American Veterinary Medicine Association, the mean starting salary for a veterinarian working predominantly in the treatment of food animals is about $85,000, but it was more than $100,000 for those who specialize in pet care. The North Dakota Department of Agriculture does work with residents interested in attending veterinary school. Carlson said her office assists with applications for veterinary loan repayment programs. "There are a few different ways that the state and federal government has approached that issue," Carlson said. While NDSU has a veterinarian technician program, there are currently no veterinary schools in North Dakota. In fact, there are only about 30 veterinary schools nationwide. The closest to North Dakota and some of the most renowned veterinary medicine schools are the University of Minnesota, University of Iowa and Kansas State. "NDSU is a great agricultural school and has a great veterinary technician program," Weyer said. "It might be nice to have a veterinary doctorate program at NDSU, but I am not sure that the population is there yet to support one."

RALEIGH, N.C. (AP) — The very close election for a North Carolina Supreme Court seat heads next to a hand recount even as election officials announced a machine recount of over 5.5 million ballots resulted in no margin change between the candidates. The statewide machine recount — in which ballots were run again through tabulators — that wrapped up this week showed Democratic Associate Justice Allison Riggs with a 734-vote lead over Republican challenger Jefferson Griffin, who is a Court of Appeals judge. Most county election boards reported minor vote changes from the machine recount requested by Griffin. But State Board of Elections data showed the post-recount lead exactly the same as what Riggs held after all 100 counties fully completed their ballot canvass in November. Griffin led Riggs by about 10,000 votes on election night, but that lead dwindled and flipped to Riggs as tens of thousands of qualifying provisional and absentee ballots were added to the totals through the canvass. Griffin, who already has pending election protests challenging the validity of more than 60,000 ballots counted statewide, has asked for a partial hand-to-eye recount, which county boards will start Wednesday or Thursday. The partial hand recount applies to ballots in 3% of the voting sites in all 100 counties, chosen at random Tuesday by the state board. Once the partial recount is complete, a statewide hand recount would be ordered if the sample results differ enough from the machine recount that the result would be reversed if the difference were extrapolated to all ballots. Riggs, who was appointed to the Supreme Court in 2023 and now seeks an eight-year term, again claimed victory Tuesday. In a campaign news release, spokesperson Embry Owen said Griffin “needs to immediately concede – losing candidates must respect the will of voters and not needlessly waste state resources.” Riggs is one of two Democrats on the seven-member court. Through attorneys, Griffin has challenged ballots that he says may not qualify for several reasons and cast doubt on the election result. Among them: voter registration records of some voters casting ballots lack driver's license or partial Social Security numbers, and overseas voters never living in North Carolina may run afoul of state residency requirements. State and county boards are considering the protests. Griffin's attorneys on Monday asked the state board to accelerate the matters before it and make a final ruling early next week. "Our priority remains ensuring that every legal vote is counted and that the public can trust the integrity of this election,” state Republican Party spokesperson Matt Mercer said in a news release. Final rulings by the state board can be appealed to state court. Joining Griffin in protests are three Republican legislative candidates who still trailed narrowly in their respective races after the machine recounts. The Supreme Court race and two of these three legislative races have not been called by The Associated Press. The key pending legislative race is for a House seat covering Granville County and parts of Vance County. Republican Rep. Frank Sossamon trails Democratic challenger Bryan Cohn by 228 votes, down from 233 votes before the recount. Sossamon also asked for a partial hard recount in his race, which was to begin Tuesday. Should Cohn win, Republicans will fall one seat short of the 72 needed in the 120-member House to retain its veto-proof majority — giving more leverage to Democratic Gov.-elect Josh Stein in 2025. Senate Republicans already have won 30 of the 50 seats needed to retain its supermajority in their chamber. The AP on Tuesday did call another legislative race not subject to a protest, as Mecklenburg County GOP Rep. Tricia Cotham won her reelection bid over Democrat Nicole Sidman. A machine recount showed Cotham ahead of Sidman by 213 votes, compared to 216 after the county canvass. Cotham’s switch from the Democrats to the Republicans in April 2023 secured the Republicans' 72-seat veto-proof majority so that Democratic Gov. Roy Cooper’s vetoes could be overridden by relying solely on GOP lawmakers. Cotham had already claimed victory weeks ago. Sidman said Tuesday in a written statement: "After a fair vote and a recount following established procedure, I accept the result in my race. In the interest of respecting the will of North Carolina's voters, I urge all candidates to accept the results in their races as well.”

The new, 12-team College Football Playoff brings with it a promise to be bigger, more exciting, more lucrative. Perfect or 100% fair? Well, nobody ever believed that. The first expanded playoff bracket unveiled Sunday left a presumably deserving Alabama team on the sideline in favor of an SMU squad that finished with a better record after playing a schedule that was not as difficult. It ranked undefeated Oregon first but set up a possible rematch against Ohio State, the team that came closest to beating the Ducks this year. It treated underdog Boise State like a favorite and banged-up Georgia like a world beater at No. 2. It gave Ohio State home-field advantage against Tennessee for reasons it would take a supercomputer to figure out. It gave the sport the multiweek tournament it has longed for, but also ensured there will be plenty to grouse about between now and when the trophy is handed out on Jan. 20 after what will easily be the longest college football season in history. All of it, thankfully, will be sorted out on the field starting with first-round games on campuses Dec. 20 and 21, then over three succeeding rounds that will wind their way through traditional bowl sites. Maybe Oregon coach Dan Lanning, whose undefeated Ducks are the favorite to win it all, put it best when he offered: "Winning a national championship is not supposed to be easy.” Neither, it turns out, is figuring out who should play for it. Alabama comes up short in the bracket’s biggest debate The Big Ten will lead the way with four teams in the tournament, followed by the SEC with three and the ACC with two. The lasting memory from the inaugural bracket will involve the decision that handed the ACC that second bid. Alabama of the SEC didn't play Saturday. SMU of the ACC did. The Mustangs fell behind by three touchdowns to Clemson before coming back to tie. But they ultimately lost 34-31 on a 56-yard field goal as time expired. “We were on pins and needles,” SMU coach Rhett Lashley said. “Until we saw the name ‘SMU’ up there, we were hanging on the edge. We're really, really happy and thankful to the committee for rewarding our guys for their total body of work." The Mustangs only had two losses, compared to three for the Crimson Tide. Even though SMU's schedule wasn't nearly as tough, the committee was impressed by the way the Mustangs came back against Clemson. “We just felt, in this particular case, SMU had the nod above Alabama,” said Michigan athletic director Warde Manuel, the chairman of the selection committee. “But it’s no disrespect to Alabama’s strength of schedule. We looked at the entire body of work for both teams.” Crimson Tide AD gracious, but looking for answers Alabama athletic director Greg Byrne was gracious, up to a point. “Disappointed with the outcome and felt we were one of the 12 best teams in the country,” he said on social media. He acknowledged — despite all of Alabama’s losses coming against conference opponents this season — that the Tide’s push to schedule more games against teams from other major conferences in order to improve its strength of schedule did not pay off this time. “That is not good for college football," Byrne said. Georgia, Boise State and Arizona State join Oregon with first-round byes Georgia, the SEC champion, was seeded second; Boise State, the Mountain West champion, earned the third seed; and Big 12 titlist Arizona State got the fourth seed and the fourth and final first-round bye. All will play in quarterfinals at bowl games on Dec. 31-Jan. 1. Clemson stole a bid and the 12th seed with its crazy win over SMU, the result that ultimately cost Alabama a spot in the field. The Tigers moved to No. 16 in the rankings, but got in as the fifth-best conference winner. Automatic byes and bids made the bracket strange The conference commissioners' idea to give conference champions preferable treatment in this first iteration of the 12-team playoff could be up for reconsideration after this season. The committee actually ranked Boise State, the Mountain West Champion, at No. 9 and Big 12 champion Arizona State at No. 12, but both get to skip the first round. Another CFP guideline: There’s no reseeding of teams after each round, which means no break for Oregon. The top-seeded Ducks will face the winner of Tennessee-Ohio State in the Rose Bowl. Oregon beat Ohio State 32-31 earlier this year in one of the season’s best games. What the matchups look like No. 12 Clemson at No. 5 Texas, Dec. 21. Clemson is riding high after the SMU upset, while Texas is 0-2 against Georgia and 11-0 vs. everyone else this season. The winner faces ... Arizona State in the Peach Bowl. Huh? No. 11 SMU at No. 6 Penn State, Dec. 21. The biggest knock against the Mustangs was that they didn't play any big boys with that 60th-ranked strength of schedule. Well, now they get to. The winner faces ... Boise State in the Fiesta Bowl. Yes, SMU vs. Boise was the quarterfinal we all expected. No. 10 Indiana at No. 7 Notre Dame, Dec. 20. Hoosiers coach Curt Cignetti thought his team deserved a home game. Well, not quite but close. The winner faces ... Georgia in the Sugar Bowl. The Bulldogs got the No. 2 seed despite a throwing-arm injury to QB Carson Beck. But what else was the committee supposed to do? No. 9 Tennessee at No. 8 Ohio State , Dec. 21. The Buckeyes (losses to Oregon, Michigan) got home field over the Volunteers (losses to Arkansas, Georgia) in a matchup of programs with two of the biggest stadiums in football. The winner faces ... Oregon in the Rose Bowl. Feels like that matchup should come in the semifinals or later. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-footballNone

AP Business SummaryBrief at 4:49 p.m. ESTAbdul Malik Kweku Baako Jnr. Declares Support for NPP Ahead of December 7 ElectionsATLANTA , Dec. 23, 2024 /PRNewswire/ -- KORE Group Holdings, Inc. (NYSE: KORE) ("KORE" or the "Company"), the global pure-play Internet of Things ("IoT") hyperscaler and provider of IoT Connectivity, Solutions, and Analytics, today announced it has received notification (the "Acceptance Letter") from the New York Stock Exchange (the "NYSE") that the NYSE has accepted the Company's previously-submitted plan (the "Plan") to regain compliance with the NYSE's continued listing standards set forth in Section 802.01B of the NYSE Listed Company Manual relating to minimum market capitalization and stockholders' equity. In the Acceptance Letter, the NYSE granted the Company an 18-month period from September 12, 2024 (the "Plan Period") to regain compliance with the continued listing standards. As part of the Plan, the Company is required to provide the NYSE quarterly updates regarding its progress towards the goals and initiatives in the Plan. In the Plan, Kore included details regarding previously reported operational restructuring activities, as well as an outlook on the Company's business. The Company expects its common stock will continue to be listed on the NYSE during the Plan Period, subject to the Company adherence to the Plan and compliance with other applicable NYSE continued listing standards. The Company's receipt of such notification from the NYSE does not affect the Company's business, operations or reporting requirements with the U.S. Securities and Exchange Commission. Cautionary Note on Forward-Looking Statements This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe," "guidance," "project," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "predict," "potential," "seem," "seek," "future," "outlook," and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding expected progress with the Company's compliance plan submitted to the NYSE, expected compliance with continued listing standards of the NYSE and expected continued listing of the Company's common stock on the NYSE. These statements are based on various assumptions and on the current expectations of KORE's management. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor or other person as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of KORE. These forward-looking statements are subject to a number of risks and uncertainties, including general economic, financial, legal, political and business conditions and changes in domestic and foreign markets; the potential effects of COVID-19; risks related to the rollout of KORE's business and the timing of expected business milestones; risks relating to the integration of KORE's acquired companies, including the acquisition of Twilio's IoT business, changes in the assumptions underlying KORE's expectations regarding its future business; our ability to negotiate and sign a definitive contract with a customer in our sales funnel; our ability to realize some or all of estimates relating to customer contracts as revenue, including any contractual options available to customers or contractual periods that are subject to termination for convenience provisions; the effects of competition on KORE's future business; and the outcome of judicial proceedings to which KORE is, or may become a party. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that KORE presently does not know or that KORE currently believes are immaterial that could also cause actual results to differ materially from those contained in the forward-looking statements. In addition, forward-looking statements reflect KORE's expectations, plans or forecasts of future events and views as of the date of this press release. KORE anticipates that subsequent events and developments will cause these assessments to change. However, while KORE may elect to update these forward-looking statements at some point in the future, KORE specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing KORE's assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements. KORE Investor Contact: Vik Vijayvergiya Vice President, IR, Corporate Development and Strategy vvijayvergiya@korewireless.com (770) 280-0324 View original content to download multimedia: https://www.prnewswire.com/news-releases/kore-announces-nyse-acceptance-of-plan-to-regain-listing-compliance-302338621.html SOURCE KORE Group Holdings, Inc.Fake European noble to plead guilty in $6M Ponzi scheme

EAGLE ELECTRONICS ANNOUNCES FORMATION OF STATE-OF-THE-ART ELECTRONICS MANUFACTURING FACILITY, $14MM OF FUNDING, AND CUSTOMER COMMITMENTS

South Korean lawmakers seek president's impeachment after 6-hour martial law declaration


Previous: ace super jili
Next: slot super ace jili games rules